University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
The James Cancer Hospital and Solove Research Institute, Columbus

RekruttererFase 1/2

Alder 16 til 75 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT03104491

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Cincinnati Children's Hospital Medical Center, Cincinnati

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07586618

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies and Childrens Hospital, Cleveland
og 3 flere

RekruttererFase 1/2

Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Cincinnati Children's Hospital Medical Center, Cincinnati

RekruttererFase 2

Alder 7 til 25 · Alle kjønn · Oppdatert 19. aug. 2026 · NCT05082519

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Children's Hospital Medical Center, Cincinnati

RekruttererObservasjonsstudie

1 Day – 17 Years · Alle kjønn · Oppdatert 14. aug. 2026 · NCT06274788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Childrens Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital, Cincinnati
University Hospitals Case Medical Center, Cleveland
og 3 flere

RekruttererObservasjonsstudie

Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Cincinnati Children's Hospital Medical Center, Cincinnati

RekruttererFase 1/2

Opp til 21 år · Alle kjønn · Oppdatert 3. jun. 2026 · NCT04195347

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Nationwide Children's Hospital, Columbus
Ohio State University Comprehensive Cancer Center, Columbus

RekruttererFase 1

Alder 2 og eldre · Alle kjønn · Oppdatert 29. mai 2026 · NCT05418088

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati

RekruttererObservasjonsstudie

Alle aldre · Alle kjønn · Oppdatert 18. mai 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Cincinnati Children's Hospital Medical Center, Cincinnati
University of Cincinnati, Cincinnati
The Ohio State University, Columbus

RekruttererFase 1

Alder 13 og eldre · Alle kjønn · Oppdatert 5. mai 2026 · NCT04771572

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Ohio State University Medical Center, Columbus

RekruttererFase 1

Alder 18 til 65 · Alle kjønn · Oppdatert 25. mar. 2026 · NCT03533816

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

The Ohio State University Comprehensive Cancer Center, Columbus

RekruttererFase 1/2

Alder 12 og eldre · Alle kjønn · Oppdatert 24. mar. 2026 · NCT04988555

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Cleveland Clinic Foundation, Cleveland

RekruttererFase 2

Alder 18 til 54 · Alle kjønn · Oppdatert 17. mar. 2026 · NCT06918431

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Cleveland Clinic, Cleveland

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 5. nov. 2025 · NCT04260022

HPC Offered for PRESERVE Expansion

The Ohio State University Medical Center, Columbus

RekruttererObservasjonsstudie

Alder 12 til 80 · Alle kjønn · Oppdatert 28. aug. 2025 · NCT07145411

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies, Cleveland
Nationwide Children's Hospital, Columbus

RekruttererFase 1

Alder 1 til 21 · Alle kjønn · Oppdatert 6. des. 2024 · NCT05476770

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.